118
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation

, , , , , & show all
Pages 317-327 | Received 27 Mar 2002, Accepted 10 Oct 2002, Published online: 02 Jul 2010

References

  • Blanco-Prieto M. J., Besseghir K., Zerbe O., Andris D., Orsolini P., Heimgartner F., Merkle H. P., Gander B. In vitro and in vivo evaluation of somatostatin analogue released from PLGA microspheres. Journal of Controlled Release 2000; 67: 19–28
  • Feng S. S., Huang G. F. Effects of emulsifiers on the controlled release of paclitaxel (Paclitaxel®) from nanospheres of biodegradable polymers. Journal of Controlled Release 2001; 71: 53–69
  • Jiang W., Schwendeman S. P. Stabilization and controlled release of bovine serum albumin encapsulated in poly (D, L.-lactide) and poly (ethylene glycol) microsphere blends. Pharmaceutical Research 2001; 18: 878–885
  • Lee T. H. Controlled Release of Etanidazole Using Double Walled Microspheres. B. Eng. Thesis, National University of Singapore. 2002
  • Rowinsky E. K., Cazenaue L. A., Donehower R. C. Paclitaxel-a novel investigational antimicrotubule agent. Journal of National Cancer Institute 1990; 82: 1247–1259
  • Sanders L. M., Kent J. S., McRae G. I., Vickery B. H., Tice T. R., Lewis D. H. Controlled release of a luteinizing hormone-releasing hormone analogue from poly (D, L-lactide-glycolide) microspheres. Journal of Pharmaceutical Science 1984; 73: 1294–1297
  • Shameem M., Lee H., Borton K., Phanoo B. C., Deluca P. P. Effect of γ-irradiation on peptide-containing hydrophilic poly (lactide-co-glycolide) micro-spheres. PDA Journal of Pharmaceutical Science and Technology 1999; 53: 309–313
  • Spencer C. M., Faulds D. Paclitaxel: a review of its pharmacodynamic and pharmacokmetic properties and therapeutic potential in the treatment of cancer. Drugs 1994; 48: 794–847
  • Tishler R. B., Geard C. R., Hall L. J., Schiff P. B. Paclitaxel sensitizes human astrocytoma-cells to radiation. Cancer Research 1992; 52: 3459–3497
  • Walter K. A., Cahan M. A., Gur A., Tyler B., Hilton J., Colvin O. M., Burger P. C., Domb A., Brem H. Interstitial paclitaxel delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Research 1994; 54: 2207–2212
  • Wang Y. M., Sato H., Horikoshi I. In vitro and in vivo evaluation of paclitaxel release from poly (lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres. Journal of Controlled Release 1997; 49: 157–166
  • Winternitz C. I., Jackson J. K., Oktaba A. M., Burt H. M. Development of a polymeric surgical paste formulation for paclitaxel. Pharmaceutical Research 1996; 13: 368–375
  • Yu L., Bridgers A., Polli J., Vickers A., Long S., Roy A., Winnike R., Coffin M. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing solubility and permeability. Pharmaceutical Research 1999; 16: 1812–1817
  • Zhang X. C., Jackson J. K., Wong W., Min W. X., Cruz T., Hunter W. L., Burt H. M. Development of biodegradable polymeric paste formulations for paclitaxel: an in vitro and in vivo study. International Journal of Pharmaceutics 1996; 37: 199–208

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.